Injectable Nanobody Wins FDA Approval for Myasthenia Gravis
(MedPage Today) -- The FDA on Friday approved injectable gefurulimab (Klygefa), a dual-binding nanobody that blocks complement component 5 (C5) activation, to treat generalized myasthenia gravis in adults who are anti-acetylcholine receptor (AChR...
We haven't written up this one. MedPage Today has the full story — the link below goes straight to it.